Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND TGFBR2, AAT3, 7048, ENSG00000163513, P37173, TGFbeta-RII, RIIC, TAAD2, FAA3, TGFR-2, MFS2, HNPCC6 AND Treatment
10 results:

  • 1. MiR-27a-3p exacerbates cell migration and invasion in right-sided/left-sided colorectal cancer by targeting tgfbr2/TCF7L2.
    Bi L; Zhou Y; Zhang Y; Zhang X
    Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):148-154. PubMed ID: 38372101
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Specific Mutations in APC, with Prognostic Implications in Metastatic colorectal cancer.
    Peng H; Ying J; Zang J; Lu H; Zhao X; Yang P; Wang X; Li J; Gong Z; Zhang D; Wang Z
    Cancer Res Treat; 2023 Oct; 55(4):1270-1280. PubMed ID: 37114476
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA.
    Ye LF; Huang ZY; Chen XX; Chen ZG; Wu SX; Ren C; Hu MT; Bao H; Jin Y; Wang F; Wang FH; Du ZM; Wu X; Ju HQ; Shao Y; Li YH; Xu RH; Wang DS
    Drug Resist Updat; 2022 Dec; 65():100883. PubMed ID: 36202008
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular characterization of colorectal cancer using whole-exome sequencing in a Taiwanese population.
    Chang YS; Lee CC; Ke TW; Chang CM; Chao DS; Huang HY; Chang JG
    Cancer Med; 2019 Jul; 8(8):3738-3747. PubMed ID: 31127692
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The miR-371∼373 Cluster Represses Colon cancer Initiation and Metastatic Colonization by Inhibiting the tgfbr2/ID1 Signaling Axis.
    Ullmann P; Rodriguez F; Schmitz M; Meurer SK; Qureshi-Baig K; Felten P; Ginolhac A; Antunes L; Frasquilho S; Zügel N; Weiskirchen R; Haan S; Letellier E
    Cancer Res; 2018 Jul; 78(14):3793-3808. PubMed ID: 29748374
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma.
    Cammareri P; Rose AM; Vincent DF; Wang J; Nagano A; Libertini S; Ridgway RA; Athineos D; Coates PJ; McHugh A; Pourreyron C; Dayal JH; Larsson J; Weidlich S; Spender LC; Sapkota GP; Purdie KJ; Proby CM; Harwood CA; Leigh IM; Clevers H; Barker N; Karlsson S; Pritchard C; Marais R; Chelala C; South AP; Sansom OJ; Inman GJ
    Nat Commun; 2016 Aug; 7():12493. PubMed ID: 27558455
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A scoring system based on artificial neural network for predicting 10-year survival in stage II A colon cancer patients after radical surgery.
    Peng JH; Fang YJ; Li CX; Ou QJ; Jiang W; Lu SX; Lu ZH; Li PX; Yun JP; Zhang RX; Pan ZZ; Wan de S
    Oncotarget; 2016 Apr; 7(16):22939-47. PubMed ID: 27008710
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic markers for metastatic colon cancer patients undergoing multiple metastasectomies.
    Öven Ustaalioğlu BB; Tilki M; Kılıçoğlu ZG; Bilici A; Sürmelioğlu A; Ustaalioğlu R; Erkol B
    Turk J Gastroenterol; 2015 Sep; 26(5):386-91. PubMed ID: 26215062
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A new method for detection of tumor driver-dependent changes of protein sialylation in a colon cancer cell line reveals nectin-3 as tgfbr2 target.
    Lee J; Warnken U; Schnölzer M; Gebert J; Kopitz J
    Protein Sci; 2015 Oct; 24(10):1686-94. PubMed ID: 26177744
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Suppressing TGFβ signaling in regenerating epithelia in an inflammatory microenvironment is sufficient to cause invasive intestinal cancer.
    Oshima H; Nakayama M; Han TS; Naoi K; Ju X; Maeda Y; Robine S; Tsuchiya K; Sato T; Sato H; Taketo MM; Oshima M
    Cancer Res; 2015 Feb; 75(4):766-76. PubMed ID: 25687406
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.